| Financial Year |
March 31 2023 |
| Monetary Funds |
223,405,450.36 |
| Held-for-trading Financial Assets |
966,160,530.63 |
| Notes Receivable |
-- |
| Accounts Receivable |
17,665,184.39 |
| Advances to Suppliers |
2,729,296.34 |
| Other Receivables |
1,702,490.57 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,202,784.98 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
21,645,040.78 |
| Other Current Assets |
3,584,033.70 |
| Total Current Assets |
1,238,094,811.75 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
561,465,649.86 |
| Investment Properties |
58,572,883.78 |
| Fixed Assetes |
70,003,635.73 |
| Under-construction Projects |
8,014,760.17 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
46,406,875.44 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
40,781,800.06 |
| Deferred Income Tax Assets |
5,032,051.49 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
1,392,171,345.30 |
| Total Assets |
2,630,266,157.05 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
53,885,828.84 |
| Accounts Received In Advance |
29,649,483.93 |
| Employee Compensation Payable |
6,799,896.30 |
| Taxes Payable |
13,388,106.95 |
| Interest Payable |
-- |
| Dividend Payable |
1,063,461.65 |
| Other payables |
55,758,872.31 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
2,752,233.57 |
| Sub-Total of Current Liabilities |
191,763,780.14 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
27,312,066.67 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
59,560,542.25 |
| Total Liabilities |
251,324,322.39 |
| Paid-In Capital(Or Share Stock) |
376,240,316.00 |
| Capital Surplus |
233,656,246.73 |
| Surplus Reserve |
194,545,479.23 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,574,253,448.58 |
| Minority Stockholder's Interest |
164,071.82 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,378,777,762.84 |
| Owner's Equity（Stockholder's Equity） |
2,378,941,834.66 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,630,266,157.05 |
